Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Genitourinary 42Gastrointestinal 31Thoracic 16Gynecologic 16Breast 14Lymphoid 13CNS 12Other hematologic neoplasm 11Head & Neck 11Dermatologic 8Other solid neoplasm 5Tumor-Agnostic 4Sarcoma 4Plasma cell 3Other neoplasm 3Myeloid 3NET 1Endocrine 1Classical hematology 1

Conditions

Neoplasms 3Neoplasm Metastasis 1

Interventions

pembrolizumab 95Paclitaxel 86Gemcitabine 84Carboplatin 79Surveys and Questionnaires 72Docetaxel 61Bevacizumab 61Nivolumab 59Cisplatin 59Magnetic Resonance Spectroscopy 50Blood Specimen Collection 50Fluorouracil 48Capecitabine 47Radiotherapy 46Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 38Biopsy 36atezolizumab 35Leucovorin 35Pemetrexed 34Standard of Care 32Cetuximab 32Specimen Handling 31Trastuzumab 30Radiosurgery 29Ipilimumab 28Cyclophosphamide 28Interviews as Topic 27olaparib 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Watchful Waiting × Tumor-Agnostic × Clear all
NCT06745024 2026-05-04

Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial

NRG Oncology

Phase 3 Active not recruiting
280 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT05574738 2024-02-08

A Study to Explore Biomarkers in Samples of Blood, Urine, Stools, Hair Follicles and Saliva From Patients With Cancer

Cancer Research UK, Glasgow

Unknown
1,000 enrolled
Tumor-Agnostic

Neoplasms

NCT02978846 2018-10-05

Perceptions of Side Effects of Cancer Chemoradiotherapy

University of Southern California

Completed
62 enrolled
Tumor-Agnostic

Neoplasms

NCT03561467 2018-06-19

PARCOURS

University Hospital, Caen

Unknown
60 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡